Zantac

Zantac lawsuits claim that the manufacturers of the heartburn medication Zantac failed to warn the public about the drug's potential to cause cancer: 

• AllegationsPlaintiffs claim that Zantac's active ingredient, ranitidine, can break down into N-nitrosodimethylamine (NDMA), a probable human carcinogen, when exposed to heat or over time. They also claim that the manufacturers failed to warn the public about this risk, and that they prioritized profit over consumer safety. 
• LawsuitsLawsuits have been filed in multiple states, including California, Delaware, and Pennsylvania. 
• SettlementsSome companies have settled Zantac lawsuits, including: 
  • Pfizer: Agreed to settle over 10,000 lawsuits for a reported $200–$250 million 
  • Sanofi: Agreed to pay over $100 million to settle about 4,000 lawsuits 
  • GSK: Settled two confidential cases in California State Court and one in Illinois State Court